Improving quality of life</br>and community responsibility
Improving quality of life
and community responsibility
BATIVIV
Indications: Treatment of diarrhea, Helicobacter pylori infection and peptic ulcer (gastric and duodenal ulcers), and dyspepsia.
The packaging specification   Box of 3 blisters × 10 chewable tablets

Active Ingredient - Concentration

Bismuth subsalicylate 262mg

Function Group Gastrointestinal
Dosage Form Chewable tablet

 

Dosage and Administration:

Treatment of H. pylori infection and duodenal ulcer:
Adults: Take 2 tablets in combination with 250 mg metronidazole and 500 mg tetracycline hydrochloride, four times daily for 10–14 days. Administer concurrently with 150 mg ranitidine twice daily or a proton pump inhibitor at the standard dose once or twice daily.
For diarrhea/dyspepsia:
Adults and children ≥16 years: Take 2 tablets every 30–60 minutes as needed; or 4 tablets every hour if required, not exceeding 16 tablets within 24 hours. Continue treatment until diarrhea stops, but not for more than 2 days. Alternatively, 4 tablets may be taken every 30 minutes to 1 hour as needed, not exceeding 16 tablets per 24 hours. Self-medication should not exceed 2 consecutive days.

Administration: For oral use. Chew the tablets or allow them to dissolve in the mouth before swallowing.

Storage:

• Store in a cool, dry place, protected from direct sunlight, at a temperature not exceeding 30 °C.
• Keep out of the reach of children.

Expiration date: 

36 months from the date of manufacture.

Manufacturer: DRP Inter Co., Ltd.

Made in: Vietnam

Featured Products
Nervous
Box of 3 blisters × 10 tablets
TOFIPAM

Indications:
Treatment of mental (neurological) and somatic disorders associated with stress, anxiety, autonomic dysfunction, lack of energy and motivation, apathy, fatigue, and depressed mood.

Composition: 
Tofisopam 50mg

Nervous
Box of 3 blisters x 10 tablets.
FIRVOMEF 25/100 MG

Indications:
Treatment of Parkinson's disease and syndrome.

 

Ingredients:
Carbidopa 25 mg

Levodopa 100 mg

Nervous
Box of 3 blister packs, each containing 10 tablets.
FIRVOMEF 25/250 MG
Indications:
Treatment of Parkinson's disease and Parkinsonian syndromes.

Ingredient
Carbidopa 25 mg
Levodopa 250 mg
New
Nervous
Box containing 3 blisters x 10 tablets
FIRVOMEF 10/100 MG

Indication:
Treatment of Parkinson's disease and Parkinsonian syndromes.

 

Ingredients:
Carbidopa: 10 mg
Levodopa: 100 mg